跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Guiacof Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Guiacof Plus
Approved
STANDARD
Guiacof Plus
Diamond Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fe0b09c3e9574997
Company
Diamond Laboratories Inc.
Type
Standard
Approval Details
Approval Id
fe0b09c3e9574997
Drug Approval Philippines Name
Guiacof Plus
Product Name
Guiacof Plus
Registration Number
DRP-6939
Brand Name
Guiacof Plus
Generic Name
Salbutamol (as Sulfate) + Guaifenesin
Dosage Form
Capsule
Dosage Strength
2 mg/100 mg
Manufacturer
Diamond Laboratories Inc.
Distributor
Rilem Pharma Corp.
Issuance Date
27 September 2021
Expiry Date
11 November 2026
Pharmacologic Category
Selective beta-2-adrenoceptor agonist / Expectorant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fe0b09c3e9574997
Type
Standard
Back to Philippines FDA Approvals